68682-002 : Bexarotene 1 g/100g Topical Gel
NDC: | 68682-002 |
Labeler: | Oceanside Pharmaceuticals |
Product Type: | Human Prescription Drug |
Drug Name: | Bexarotene |
Dosage Form: | Topical Gel |
Application #: | NDA021056 |
Rev. Date: |
NDC Package Codes:
- 68682-002-60: 60 G IN 1 TUBE (68682‑002‑60)
Active Ingredients:
- Bexarotene
Dosage Strength:
- 1 g/100g
Pharmaceutical Classes:
- Retinoid [EPC]
- Retinoids [Chemical/Ingredient]
Related Products:
Based on records with the same trade name.- 68682-003 Bexarotene 75 mg Oral Capsule, Liquid Filled by Oceanside Pharmaceuticals
- 0054-0399 Bexarotene 75 mg Oral Capsule, Liquid Filled by Hikma Pharmaceuticals USA Inc.
- 0378-6955 Bexarotene 75 mg Oral Capsule, Liquid Filled by Mylan Pharmaceuticals Inc.
- 0591-2832 Bexarotene 75 mg Oral Capsule, Liquid Filled by Actavis Pharma, Inc.
- 0832-0285 Bexarotene 75 mg Oral Capsule by Upsher-smith Laboratories, Inc.
- 42291-072 Bexarotene 75 mg Oral Capsule by Avkare
- 42292-007 Bexarotene 75 mg Oral Capsule, Liquid Filled by Mylan Institutional Inc.
- 43975-315 Bexarotene 75 mg Oral Capsule, Liquid Filled by Amerigen Pharmaceuticals Inc.
- 69238-1250 Bexarotene 75 mg Oral Capsule by Amneal Pharmaceuticals LLC
- 69238-2088 Bexarotene 10 mg/g Topical Gel by Amneal Pharmaceuticals Ny LLC
NDC QR Code
Scan the QR code below to easily reference this data in the future:< Prev: 68682-001Next: 68682-003 >
Related Discussions:
Bexarotene for Alzheimer's
Hi - has anyone else heard about the research being done on Bexarotene as a viable Alzheimer's treatment? Apparently... 4 replies
Hi - has anyone else heard about the research being done on Bexarotene as a viable Alzheimer's treatment? Apparently... 4 replies
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.